n-palmitoylsphingosine and Obesity

n-palmitoylsphingosine has been researched along with Obesity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Al Ali, A; Alghamdi, HM; Alsaif, HS; Alshomimi, S; Chathoth, S; Cyrus, C; Hassan, KA; Ismail, MH; Mostafa, A; Shaaban, H; Vatte, C; Zakaria, HM1
Aslan, İ; Aslan, M; Aydın, D; Çeker, T; Koca, Y; Öztüzün, A; Yılmaz, Ç1
Bielohuby, M; Bruning, JC; Brunner, B; Hansen, G; Larsen, PJ; Pfenninger, A; Raichur, S; Tennagels, N; Wang, B1
Alsahli, A; Cremers, S; Gold, T; Jiang, H; Kiefhaber, K; Muluke, M; Schulze-Späte, U1

Other Studies

4 other study(ies) available for n-palmitoylsphingosine and Obesity

ArticleYear
Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
    Lipids in health and disease, 2022, Feb-20, Volume: 21, Issue:1

    Topics: Ceramides; Chromatography, Liquid; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Obesity; Tandem Mass Spectrometry

2022
Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients.
    Prostaglandins & other lipid mediators, 2023, Volume: 166

    Topics: Ceramides; Cholesterol, HDL; Cholesterol, LDL; Chromatography, Liquid; Diabetes Mellitus, Type 2; Humans; Lipoproteins, HDL; Obesity; Sphingomyelins; Tandem Mass Spectrometry

2023
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
    Molecular metabolism, 2019, Volume: 21

    Topics: Adipose Tissue, Brown; Animals; Blood Glucose; Ceramides; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Knockdown Techniques; Hep G2 Cells; Humans; Insulin Resistance; Leptin; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oligonucleotides, Antisense; Sphingosine N-Acyltransferase; Thionucleotides; Weight Gain

2019
Palmitic Acid Reduces Circulating Bone Formation Markers in Obese Animals and Impairs Osteoblast Activity via C16-Ceramide Accumulation.
    Calcified tissue international, 2016, Volume: 98, Issue:5

    Topics: Absorptiometry, Photon; Animals; Biomarkers; Ceramides; Diet, High-Fat; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Male; Mice; Mice, Inbred C57BL; Obesity; Oleic Acid; Osteoblasts; Osteogenesis; Palmitic Acid

2016